Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry

Maria Knoph Kvamme(University of Oslo), Ivar Sønbø Kristiansen(University of Southern Denmark)

Lara D. Veeken

April 25, 2012

10.1093/rheumatology/kes074

Cited by 60

Related Papers

Cost‐effectiveness of low‐dose <scp>CT</scp> lung cancer screening among individuals that have ever smoked in Norway: A model‐based analysis using <scp>NELSON</scp> trial criteria and outcomes

|International Journal of Cancer|2025|1